Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
Venrock Healthcare Capital Partners III, L.P. - 31 Mar 2026 SCHEDULE 13G/A Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)
- Filing manager
- Venrock Healthcare Capital Partners III, L.P.
- Reporting owner
- Venrock Healthcare Capital Partners III, L.P.
- Beneficially owned shares
- 1,955,105 shares
- Large-stake signal
-
Ownership
9.9%Beneficial ownership of this reported class.
Shares
1,955,105 sharesShares beneficially owned as disclosed.
Event date
31 Mar 2026Date tied to the ownership event or amendment.
Accepted by SEC
15 May 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 9.9%
- Symbol
- TENX
- Shares outstanding
- 19,748,535 shares
- SEC form
- SCHEDULE 13G/A
- Accepted by SEC
- 15 May 2026, 16:31:31 UTC
- Event date
- 31 Mar 2026
- Prior SEC filing
- 17 Feb 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Venrock Healthcare Capital Partners III, L.P. disclosed 9.9% ownership in Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX) on 31 Mar 2026.
Key facts
- Venrock Healthcare Capital Partners III, L.P. filed SCHEDULE 13G/A for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 9.9%.
- Date of event: 31 Mar 2026.
Change
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 15 May 2026, 16:31.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (7)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | 1,955,105 | 0 | 1,955,105 | /s/ Sherman G. Souther | By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory | |
| VHCP Co-Investment Holdings III, LLC | 9.9% | 1,955,105 | 0 | 1,955,105 | /s/ Sherman G. Souther | By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory | |
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | 1,955,105 | 0 | 1,955,105 | /s/ Sherman G. Souther | By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory | |
| VHCP Management III, LLC | 9.9% | 1,955,105 | 0 | 1,955,105 | /s/ Sherman G. Souther | By Sherman G. Souther, Authorized Signatory | |
| VHCP Management EG, LLC | 9.9% | 1,955,105 | 0 | 1,955,105 | /s/ Sherman G. Souther | By Sherman G. Souther, Authorized Signatory | |
| Nimish Shah | 9.9% | 1,955,105 | 0 | 1,955,105 | /s/ Sherman G. Souther | By Sherman G. Souther, Attorney-in-fact | |
| Bong Y. Koh | 9.9% | 1,955,105 | 0 | 1,955,105 | /s/ Sherman G. Souther | By Sherman G. Souther, Attorney-in-fact |
CIK / CUSIP context first